Solid Tumor Clinical Trials in Providence, Rhode Island

4 studies are recruiting for solid tumor in Providence, Rhode Island right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

    This is a Phase Ia/Ib open-label, dose-escalation study to evaluate the safety and pharmacokinetics of ROSE12 as a single agent and in combination with other anti-tumor agents in patients with locally advanced or metastatic solid tumors. The study will consist of three parts: a dose-escalation part…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rhode Island Hospital, Providence, Rhode Island
    Locations
    14 in total
    Run by
    Chugai Pharmaceutical

    See if you can join NCT05907980 on ClinicalTrials.gov

  2. A Study of PYX-201 in Advanced Solid Tumors

    The primary objectives of this study are to determine the recommended dose(s) of PYX-201 for participants with recurrent/metastatic (R/M) solid tumors, and to determine the objective response rate (ORR) in participants treated with PYX-201 as a single agent.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rhode Island Hospital, Providence, Rhode Island
    Locations
    29 in total
    Run by
    Pyxis Oncology, Inc

    See if you can join NCT05720117 on ClinicalTrials.gov

  3. A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

    This is a Phase 1/2, open label, multiple cohort study to assess the safety and preliminary efficacy of SAR445877 as a monotherapy or in combination with other anticancer therapies for participants aged at least 18 years with advanced unresectable or metastatic solid tumors. The study will include …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rhode Island Hospital - Providence - Eddy Street- Site Number : 8400004, Providence, Rhode Island
    Locations
    22 in total
    Run by
    Sanofi

    See if you can join NCT05584670 on ClinicalTrials.gov

  4. A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

    This is a Phase 1b open-label, multicenter study, evaluating the safety, tolerability, preliminary clinical activity, pharmacokinetics (PK), and pharmacodynamics of azenosertib (ZN-c3) in combination with other drugs.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Site 0191, Providence, Rhode Island
    Locations
    24 in total
    Run by
    K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

    See if you can join NCT04516447 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.